Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study pits two triple inhalers Head-to-Head for asthma relief

NCT ID NCT07282886

Recruiting now Disease control Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jan 10, 2026 · Last updated May 15, 2026 · Updated 18 times

Summary

This study tests whether a newer extrafine inhaler (Trimbow) works better than a standard one (Trelegy) for people with moderate to severe asthma that is not well controlled. Researchers will use special MRI scans to see how well the medicine reaches the lungs and measure breathing and symptom control. The study needs 20 adults aged 18 to 75 with uncontrolled asthma despite current treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The University of Alabama at Birmingham

    RECRUITING

    Birmingham, Alabama, 35233, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

ASTHMA